Nigeria: Nigeria, Barbados, Afreximbank Advance $32m Pharmaceutical Project

What the report says

Nigeria, Barbados and the African Export-Import Bank have advanced a $32 million pharmaceutical manufacturing project designed to expand medicine production and deepen trade links between Africa and the Caribbean. According to Leadership’s report carried by AllAfrica, the plan centers on an intravenous fluids plant in Barbados, with an initial annual output target of 12 million units and room to scale up.

The agreements were signed on the sidelines of the 2026 Commonwealth Heads of Government Meeting in St John’s, Antigua and Barbuda. The partnership brings together the two governments, Barbados Pharmaceutical Inc. (BPI), Nigerian manufacturer AMA Medical Manufacturing and Afreximbank. One agreement is a memorandum of understanding between BPI and AMA, while another is a Project Preparation Facility term sheet between AMA and Afreximbank, which is intended to support the financing process.

The project still needs feasibility work, financing, regulatory approvals and construction before production can begin, with output targeted for 2029 if the plan moves ahead. Leaders cited the initiative as a way to strengthen health security, support supply-chain resilience and create jobs and skills transfer across the two regions.

The report also notes that the effort builds on existing commerce between Nigeria and Barbados, including an AMA shipment of IV fluids to Barbados in March 2026, with more shipments planned for other Caribbean markets. Barbados has also recently moved to create a medical products regulator, which may be relevant as the project advances.